🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Targeting rapid TKI-induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3/ITD acute myeloid leukemia ➡️ buff.ly/eFq3UeO #TherapyResistance #CancerTherapy

Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer 👉 buff.ly/YjcZ12B #Th1 #PDAC #DendriticCells #Tcells

📢Call for papers 📭Submit your latest research in the field of #LiquidBiopsy ➡️Format: Research Article, Short Report or Method ➡️Details buff.ly/ATND9t1 #ACTC2025 #CTC #ctDNA #Cancer

❌Clear your calendars! 🧠EACR Cancer Neuroscience🧠 ⏰Abstract deadline Jun 30 👇Register by Sept 15 💡 buff.ly/dJvr9JR #CancerResearch #BrainTumours #CNScancer #NeuroOncology

Congratulations to Harsimran Kaur from Ken Lau Lab for winning the Poster Prize at the Beatson International Cancer Conference 2025! Thanks to Molecular Oncology for sponsoring this prize #BICC2025

Dose-dependent induction of epithelial-mesenchymal transition in 3D melanoma models by non-thermal plasma treatment 🔗 buff.ly/1vm7cgv #Melanoma #PlasmaMedicine

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab 👉 buff.ly/aVjT1No 🖊️ Charles Swanton David R. Spigel, MD, FASCO Hanna Tukachinsky Amaya Gascó MD PhD #ctDNA #Metastasis #Atezolizumab

Molecular imaging predicts trastuzumab-deruxtecan (T-DXd) response in head and neck cancer xenograft models ➡️ buff.ly/29qNX19 🖊️ Muhammad Bilal Mirza Eben L Rosenthal, MD #CancerImaging #HNSCC #TherapyResponse

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer 👉 buff.ly/T8VTQ6d #CCR9 #PCSM #Antibodies

Could androgen receptor co-regulators be promising treatment targets for advanced #ProstateCancer? DAMIEN LEACH, Prof. Charlotte Bevan and team Imperial Medicine investigate the role of two important co-regulators, writing in Molecular Oncology Grab a ☕ and read: doi.org/10.1002/1878-0…

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl-xL or Mcl-1 in ovarian cancer 👉 buff.ly/Yt7gh6A #HDACi #Belinostat #OvarianCancer #CellDeath

Unraveling LINE-1 retrotransposition in head and neck squamous cell carcinoma ➡️ buff.ly/9WIHa3P 🥼 María Gallardo Ramon Garcia-Escudero Jose Tubio’s lab - Mobile Genomes #Retrotransposition #HNSCC #LINE1

⚠️Hold your pipettes! ⚕️EACR Goodbye Flat Biology: ex vivo to in vivo models of cancer⚕️ ⏰Abstract deadline Jun 23 👇Register by Aug 26 eacr.org/conference/goo… #CancerModels #CancerModel #PreclinicalResearch #ModelOrganisms #TumourModels

🥳 We are excited to be attending #EACR2025! 📍 Find us at booth 45 to discuss your latest research projects, pitch an idea or get more information about publishing your paper in Molecular Oncology ℹ️ You may also want to learn more about grants available and getting involved

#EACR2025 annual meeting just started! Wonderful setting, amazing program! #liquidbiopsy, #CTC, #ctDNA

💡The Joint EACR - EACS - Molecular Oncology Session: Keep Research Curious has now started with Jan Hoeijmakers on DNA damage, cancer and aging and the unexpected impact of nutritional interventions 💡 #EACR2025

📣 Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’ are now available online! 🔎 Find them here 👉 buff.ly/a3PQo3N 🔓 #EACR2025 #EACR #CancerResearch #CancerBiology #CancerResearchers